The prostate biopsy examination involves taking several samples of prostate tissue, which are then examined under a microscope. Samples containing cancer cells are said to be positive, while the others are said to be negative.
Please refer to our What is a prostate biopsy? page for a complete and detailed explanation.
Prostate biopsy is a fast recovery procedure. However, during the prostate biopsy, you may feel discomfort rather than pain. Nowadays, innovative techniques like MRI/US fusion technology may allow you to experience less discomfort. With the KOELIS Trinity®, MRI/US fusion prostate biopsies reduce the number of samples due to a more efficient, targeted procedure leading to an accurate diagnosis. Fewer samples mean less pain.
A transrectal or transperineal biopsy procedure can take approximately 30 minutes.
Biopsy procedures can be performed under general or local anaesthesia, for both transrectal and transperineal approaches.
Active surveillance involves monitoring the tumor and its growth based on a strict schedule of visits with a urologist. During each visit, several tests are performed, including a test to check the prostate-specific antigen (PSA) level in the blood. If there are signs that the disease is progressing, treatment decisions are made.
For more information, please refer to the following page: Active Surveillance
KOELIS Trinity® assists urologists in performing effective and effortless targeted treatments using the transrectal or transperinealapproach. KOELIS provides a comprehensive tool that will help clinicians optimize their intervention thanks to the precise planning and live guidance of any needle-based prostate cancer therapy technique, such as brachytherapy, IRE, or cryotherapy.
Approximately 200,000 patients in more than 30 countries have benefited from KOELIS® Technology.
An MRI may be performed when a suspicious PSA is detected. MRI is required for fusion biopsy and is used to estimate the presence and aggressiveness of cancer through image analysis and to decide whether or not a prostate biopsy is necessary. Your general practitioner will guide you through these steps and advise you whether you should have an MRI or not.
From the MRI scan of the prostate, you get your MRI prostate image. Then, a radiologist analyzes the image to determine any areas suspected of having cancer, and a report is provided with all the data from the MRI images.
The biopsy physician, usually a urologist, will then import this MRI image of the prostate into KOELIS Trinity®, and the fusion software will fuse the prostate MRI image with the prostate ultrasound image. The physician will then visualize the MRI data during the biopsy procedure, helping him target the suspected areas.
KOELIS® fusion biopsy is guided by MRI information under ultrasound examination, allowing accurate targeting and quality control of biopsy cores, whereas routine biopsy does not allow for easy targeting and is performed “blind.”
Prostate biopsy is a routine procedure. For more information, please refer to your practitioner.
Today, there are several treatment options for prostate cancer. Please discuss these options with your practitioner, who will be able to advise you on the best course of action.